I understand this argument that ineptness has allowed accumulation. I don't think it is very good one. Nor part of the plan. No one hopes the CEO of their company makes the same mistakes over and over again for a few years to keep the stock price low.
Red, where the "waste" is most impactful is for those AD sufferers and their families as a cure/remedy has been delayed to the point that it will not be able to help the sufferers. I have always preferred speed to get this effective drug into their hands/minds.
That is what this drug is all about, first and foremost!
With potentially disruptive companies like AVXL, whether drugs, technologies or anything innovative that takes time to production and revenue stages, trading shares plus core shares is a great strategy IMO. Can create current profits, increase future profits, lower risk and other positives.
Glad to hear you and your group have accumulated sll along like many others here during the “delay”.
As we near approval I would think longs should heavily consider not catering to the likes of AF and other who are heavily shorting Anavex. After a decade lets make them squirm a little bit by calling back all the shares.